{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-038235","form_type":"8-K","ticker":"CBUS","cik":"0001705843","company_name":"Cibus, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.116969+00:00","generated_at":"2026-06-08T07:01:42.582774+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cibus Q3 2023 net loss $34.5M; cash runway only into early Q1 2024","bullets":["Net loss of $34.5M ($1.59 per share) vs. $6.0M a year ago; R&D spend jumped to $17.5M.","Cash and equivalents $31.9M; company warns cash covers only planned ops into Q1 2024.","Strategic realignment & cost cuts initiated to focus on late-stage traits; no revenue reported.","Completed field trials for PSR canola, HT1/HT3 rice; returned edited germplasm to 2 of 10 customers.","UK field trials for PSR in WOSR started; EU proposed gene-editing rules seen as favorable."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-038235","json":"https://secwatch.observer/filing/0001628280-23-038235.json","markdown":"https://secwatch.observer/filing/0001628280-23-038235.md","text":"https://secwatch.observer/filing/0001628280-23-038235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/0001628280-23-038235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/cbus-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:01:42.582774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"84536926b74ffe10a06532f65700197644ec7c65","claim":"Cibus, Inc. reported financial results for the three months ended September 30, 2023.","evidence_excerpt":"On November 9, 2023, Cibus, Inc. (the “Company”) announced its financial results for the three months ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023038235/0001628280-23-038235-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}